Svelta Labs
Svelta Labs science for weight, wellness and skin
Svelta Labs Journal

Svelta Labs Education & Research Journal

Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.

Obesity, Sleep Apnoea and Cancer: Revisiting an Interconnected Triad
Weight science 18 Nov 2026

Obesity, Sleep Apnoea and Cancer: Revisiting an Interconnected Triad

A captured review excerpt argues that obesity, obstructive sleep apnoea and cancer form an interconnected triad, and that oxygen-desaturation measures may predict cancer-related outcomes better than the standard apnoea-hypopnoea index.

Hair Loss Concerns with Mounjaro: A Lived Experience Perspective
Wellbeing 18 Nov 2026

Hair Loss Concerns with Mounjaro: A Lived Experience Perspective

Some users report hair loss after increasing their Mounjaro dose, raising questions about this side effect's nature and duration. This article explores the lived experience and current understanding.

What a Reddit Thread on Stomach Cramps During Weight-Loss Treatment Actually Shows
Wellbeing 15 Oct 2026

What a Reddit Thread on Stomach Cramps During Weight-Loss Treatment Actually Shows

A captured Reddit discussion about stomach cramps during weight-loss treatment offers a useful lesson in reading community experience carefully — and in separating it from verified evidence.

Semaglutide and Athletic Performance: A New Clinical Trial in Runners
Research 15 Oct 2026

Semaglutide and Athletic Performance: A New Clinical Trial in Runners

A new randomised placebo-controlled trial will examine how short-term semaglutide affects body composition, muscle function, running economy and performance in well-trained runners.

Brain Stimulation and Weight Loss: What a Phase 2 Trial Explored
Research 15 Oct 2026

Brain Stimulation and Weight Loss: What a Phase 2 Trial Explored

A registered Phase 2 study set out to test whether electrical stimulation of the dorsolateral prefrontal cortex changed food intake and weight over four weeks, alongside weight-loss counselling. Here is what the record actually describes, and what it does not.

TQF3250 Clinical Trial: Phase 1b Diabetes Research
Research & Clinical Trials

TQF3250 Clinical Trial: Phase 1b Diabetes Research

Read the TQF3250 Phase 1b trial design for type 2 diabetes and overweight or obesity, including safety outcomes and the limits of early research.

GLP-1 Muscle Loss and Powerlifting: What to Monitor
Wellbeing

GLP-1 Muscle Loss and Powerlifting: What to Monitor

Explore muscle-loss concerns around GLP-1 medicines and powerlifting, including strength, nutrition, recovery and the limits of body-composition measures.

Weight Loss Injections and Gallstones: Questions to Ask
Wellbeing

Weight Loss Injections and Gallstones: Questions to Ask

Have gallstones and considering weight loss injections? Understand the questions for a prescriber, relevant history and symptoms needing urgent help.

Restarting Wegovy After a Break: UK Review Checklist
Product Literacy

Restarting Wegovy After a Break: UK Review Checklist

Restarting Wegovy after a break? Check the right UK leaflet, prepare your treatment history and understand why multiple missed doses need review.

Mounjaro Itching: Skin and Injection-Site Reactions
Wellbeing

Mounjaro Itching: Skin and Injection-Site Reactions

Understand Mounjaro itching, recognised injection-site reactions, other possible causes and symptoms that need prompt medical attention.

Retatrutide Claims Online: How to Check the Evidence
Research Use & Product Literacy

Retatrutide Claims Online: How to Check the Evidence

Check retatrutide claims against trial and regulatory information. Learn why online prices, seller claims and anecdotes are not proof of approval.

Restarting Mounjaro After a Break and Weight Regain
Wellbeing

Restarting Mounjaro After a Break and Weight Regain

Considering restarting Mounjaro after a break? Understand what a personal account can show and which questions to take to your prescribing team.

Switching from Mounjaro to Wegovy: What to Discuss
Wellbeing

Switching from Mounjaro to Wegovy: What to Discuss

Compare Mounjaro and Wegovy, understand why side effects vary, and prepare questions for a prescriber before changing weight-management medicines.

Starting Mounjaro: Portion Control and Everyday Support
Wellbeing

Starting Mounjaro: Portion Control and Everyday Support

Starting Mounjaro? Explore portion control, appetite, daily routines and community support, while keeping personal experiences separate from medical advice.

Weight-Loss Injection Eligibility Below BMI 27: What Off-Label Means
Wellbeing

Weight-Loss Injection Eligibility Below BMI 27: What Off-Label Means

Starting treatment below BMI 27 is different from reaching that BMI during weight maintenance. Learn how initial BMI, indication and NHS criteria differ.

Retatrutide Approval Status: Clinical Trials, Not a Licensed Rollout
Research-Use Products

Retatrutide Approval Status: Clinical Trials, Not a Licensed Rollout

Retatrutide remains investigational in the manufacturer’s current information. Claims of a limited public rollout should not be confused with clinical-trial access.

First Mounjaro Injection Nerves: Preparation and Support
Wellbeing

First Mounjaro Injection Nerves: Preparation and Support

First-injection nerves are understandable. Focus on knowing whom to ask, using the supplied instructions and getting support if anxiety makes treatment difficult.